← ANALYSTS · TIPRANKS
Sam Slutsky · LifeSci Capital
Hits
55%
275 of 496 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+49.4%
Over a year after the rating, TipRanks’ measure
Our companies rated now
18
Buy / hold / sell: 17 / 1 / 0
Upside of the analyst’s targets
+206.1%
Average over 17 current targets, to the last price
The market’s answer to the ratings
+5.5%
Day-0 move against SPY in the rating’s direction, average over 7 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 6on TipRanks 11:30 | AVBPIWMArriVent BioPharma, Inc. · $828M | Reiterated | Buy | $43.00 → $15.00−65.1% | −10.0% | −47.5%next day +12.2% · 5 days +6.8% | ↗ |
| Oct 3on TipRanks 10:30 | CLDXIWMCelldex · $2.3B | Reiterated | Buy | $56.00 → $64.00+14.3% | +132.5% | +2.3%next day −5.4% · 5 days −10.1% | ↗ |
| Sep 30on TipRanks 08:55 | DBVTDBV Technologies SA - American · $719M | Reiterated | Buy | $45.00 | +397.2% | +2.0%next day −4.9% · 5 days −18.8% | ↗ |
| Sep 28on TipRanks 00:40 | CLDXIWMCelldex · $2.3B | Assigned | Buy | $56.00 → $64.00+14.3% | +132.5% | +2.0%next day +0.7% · 5 days +2.3% | ↗ |
| Sep 26on TipRanks 10:30 | PYXSPyxis Oncology · $240M | Reiterated | Buy | $6.00 → $8.00+33.3% | +376.2% | +2.1%next day +0.2% · 5 days −24.0% | ↗ |
| Sep 26on TipRanks 10:30 | IMVTIWMImmunovant · $5.8B | Reiterated | Buy | $53.00 | +98.3% | +1.3%next day +0.1% · 5 days −1.9% | ↗ |
| Sep 23on TipRanks 12:55 | ORKAIWMOruka Therapeutics · $4.9B | Reiterated | Buy | $175 | +143.3% | −4.2%next day −4.8% · 5 days −6.7% | ↗ |
| Sep 22on TipRanks 07:10 | ABVXAbivax SA Sponsored ADR · $8.6B | Reiterated | Buy | $170 → $168−1.2% | +90.6% | −5.0%next day −3.5% · 5 days +1.4% | ↗ |
| Sep 19on TipRanks Sep 21 02:05 | OLMAIWMOlema Pharmaceuticals · $601M | Reiterated | Buy | $16.00 | +143.2% | −3.5%next day +0.1% · 5 days −9.6% | ↗ |
| Sep 18on TipRanks 16:35 | DMRAIWMDamora Therapeutics · $1.1B | Reiterated | Buy | $45.00 | +144.0% | −0.4%next day −1.9% · 5 days −8.2% | ↗ |
| Sep 15on TipRanks 13:11 | COGTIWMCogent Biosciences · $4.9B | Reiterated | Buy | $55.00 | +86.3% | −1.5%next day −0.2% · 5 days −2.7% | ↗ |
| Sep 14on TipRanks 15:06 | AVBPIWMArriVent BioPharma, Inc. · $828M | Reiterated | Buy | $43.00 | +158.1% | −1.0%next day −1.6% · 5 days +2.2% | ↗ |
| Sep 11on TipRanks 09:25 | IMUXImmunic · $104M | Reiterated | Buy | $56.00 | +703.4% | −4.4%next day −1.2% · 5 days −6.9% | ↗ |
| Sep 8on TipRanks 13:15 | SYREIWMSpyre Therapeutics · $7.3B | Reiterated | Buy | $116 | +45.2% | +2.6%next day −3.8% · 5 days +1.3% | ↗ |
| Sep 5on TipRanks Sep 3 10:25 | ATTOAttovia Therapeutics, Inc. · $666M | Reiterated | Buy | $45.00 | +227.7% | +3.6%next day +6.0% · 5 days −4.7% | ↗ |
| Aug 8on TipRanks Aug 7 07:30 | ELVNIWMEnliven Therapeutics · $2.9B | Assigned | Buy | $60.00 → $70.00+16.7% | +87.6% | −0.3%next day −1.7% · 5 days −3.1% | ↗ |
| Aug 7on TipRanks 11:27 | CGONIWMCG Oncology, Inc. · $5.5B | Reiterated | Buy | $108 | +80.5% | −0.3%next day +2.0% · 5 days −0.5% | ↗ |
| Aug 6on TipRanks 20:45 | ALXOIWMALX Oncology Holdings · $138M | Reiterated | Hold | — | — | −1.1%next day −1.9% · 5 days −7.1% | ↗ |
| Aug 5on TipRanks 22:47 | OKURIWMOnKure Therapeutics · $91M | Reiterated | Buy | $16.00 | +661.9% | −0.1%next day −0.9% · 5 days −7.2% | ↗ |
| Aug 5on TipRanks 08:10 | PVLAIWMPalvella Therapeutics · $1.8B | Reiterated | Buy | $225 → $236+4.9% | +96.2% | +2.1%next day +0.2% · 5 days −0.2% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗